231 related articles for article (PubMed ID: 18471961)
1. CpG island methylator phenotype (CIMP) in cancer: causes and implications.
Teodoridis JM; Hardie C; Brown R
Cancer Lett; 2008 Sep; 268(2):177-86. PubMed ID: 18471961
[TBL] [Abstract][Full Text] [Related]
2. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
3. CpG island methylator phenotypes in aging and cancer.
Toyota M; Issa JP
Semin Cancer Biol; 1999 Oct; 9(5):349-57. PubMed ID: 10547343
[TBL] [Abstract][Full Text] [Related]
4. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
[TBL] [Abstract][Full Text] [Related]
5. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
Kusano M; Toyota M; Suzuki H; Akino K; Aoki F; Fujita M; Hosokawa M; Shinomura Y; Imai K; Tokino T
Cancer; 2006 Apr; 106(7):1467-79. PubMed ID: 16518809
[TBL] [Abstract][Full Text] [Related]
6. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas.
Abe M; Ohira M; Kaneda A; Yagi Y; Yamamoto S; Kitano Y; Takato T; Nakagawara A; Ushijima T
Cancer Res; 2005 Feb; 65(3):828-34. PubMed ID: 15705880
[TBL] [Abstract][Full Text] [Related]
7. Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis.
Abe M; Watanabe N; McDonell N; Takato T; Ohira M; Nakagawara A; Ushijima T
Oncology; 2008; 74(1-2):50-60. PubMed ID: 18544995
[TBL] [Abstract][Full Text] [Related]
8. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.
Liu Z; Zhao J; Chen XF; Li W; Liu R; Lei Z; Liu X; Peng X; Xu K; Chen J; Liu H; Zhou QH; Zhang HT
Lung Cancer; 2008 Oct; 62(1):15-22. PubMed ID: 18358560
[TBL] [Abstract][Full Text] [Related]
9. Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer.
Frazier ML; Xi L; Zong J; Viscofsky N; Rashid A; Wu EF; Lynch PM; Amos CI; Issa JP
Cancer Res; 2003 Aug; 63(16):4805-8. PubMed ID: 12941799
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in methyl-group metabolism genes and risk of sporadic colorectal cancer with relation to the CpG island methylator phenotype.
Karpinski P; Myszka A; Ramsey D; Misiak B; Gil J; Laczmanska I; Grzebieniak Z; Sebzda T; Smigiel R; Stembalska A; Sasiadek MM
Cancer Epidemiol; 2010 Jun; 34(3):338-44. PubMed ID: 20381446
[TBL] [Abstract][Full Text] [Related]
11. De novo CpG island methylation in human cancer cells.
Jair KW; Bachman KE; Suzuki H; Ting AH; Rhee I; Yen RW; Baylin SB; Schuebel KE
Cancer Res; 2006 Jan; 66(2):682-92. PubMed ID: 16423997
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae.
Enomoto S; Maekita T; Tsukamoto T; Nakajima T; Nakazawa K; Tatematsu M; Ichinose M; Ushijima T
Cancer Sci; 2007 Dec; 98(12):1853-61. PubMed ID: 17900260
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of genetic and epigenetic alterations reveals CpG island methylator phenotype associated with distinct clinical characters of lung adenocarcinoma.
Shinjo K; Okamoto Y; An B; Yokoyama T; Takeuchi I; Fujii M; Osada H; Usami N; Hasegawa Y; Ito H; Hida T; Fujimoto N; Kishimoto T; Sekido Y; Kondo Y
Carcinogenesis; 2012 Jul; 33(7):1277-85. PubMed ID: 22532250
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylations in cancer cells: where do they come from?
Ushijima T; Okochi-Takada E
Cancer Sci; 2005 Apr; 96(4):206-11. PubMed ID: 15819717
[TBL] [Abstract][Full Text] [Related]
15. Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas.
Abe M; Westermann F; Nakagawara A; Takato T; Schwab M; Ushijima T
Cancer Lett; 2007 Mar; 247(2):253-8. PubMed ID: 16759796
[TBL] [Abstract][Full Text] [Related]
16. DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis.
Nakagawa T; Kanai Y; Ushijima S; Kitamura T; Kakizoe T; Hirohashi S
J Urol; 2005 May; 173(5):1767-71. PubMed ID: 15821584
[TBL] [Abstract][Full Text] [Related]
17. CpG island methylation of DNA damage response genes in advanced ovarian cancer.
Teodoridis JM; Hall J; Marsh S; Kannall HD; Smyth C; Curto J; Siddiqui N; Gabra H; McLeod HL; Strathdee G; Brown R
Cancer Res; 2005 Oct; 65(19):8961-7. PubMed ID: 16204069
[TBL] [Abstract][Full Text] [Related]
18. Biological significance of the CpG island methylator phenotype.
Suzuki H; Yamamoto E; Maruyama R; Niinuma T; Kai M
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):35-42. PubMed ID: 25016183
[TBL] [Abstract][Full Text] [Related]
19. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state.
Kanai Y; Hirohashi S
Carcinogenesis; 2007 Dec; 28(12):2434-42. PubMed ID: 17893234
[TBL] [Abstract][Full Text] [Related]
20. Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells.
Shen Y; Chow J; Wang Z; Fan G
Hum Mol Genet; 2006 Sep; 15(17):2623-35. PubMed ID: 16870691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
